Bitget App
Trade smarter
Open
HomepageSign up
Bitget>
News>
5 Altcoins Under the Radar in 2026: NEAR, QNT, ZEC, XRP and MemeToro Are Gaining Attention

5 Altcoins Under the Radar in 2026: NEAR, QNT, ZEC, XRP and MemeToro Are Gaining Attention

BitcoinSistemi2026/09/28 16:33
By: BitcoinSistemi
NEAR-2.01%ZEC-3.67%XRP-0.88%

Some altcoins gain attention long before they appear in every market headline. In 2026, five names are standing out for very different reasons: NEAR for Layer-1 activity, QNT for tokenized settlement, ZEC for privacy, XRP for payment-network strength, and MemeToro for AI-powered memecoin launches.

MemeToro gives this altcoin list a different kind of entry. It is an early-stage BNB Chain project building an open-source launchpad for memecoin creation, discovery, and future trading.

$MT is intended to power access, launch funding, rewards, staking, and future memecoin trading. The roadmap also includes prediction markets and a news portal, creating more ways for users to engage with the platform.

NEAR and QNT Are Building Two Different Infrastructure Stories

NEAR trades near $4.90 after breaking through a multi-month resistance channel. It is now consolidating between $4.79 and $5.00, while the network remains a name to watch among Layer-1 projects.

Its story is about ecosystem activity and flexible blockchain infrastructure. As users and builders look for networks that can support growing applications, NEAR is gaining attention through its technical structure and strengthening market position.

Quant is moving for a different reason. QNT trades around $254 after soaring 350% in one week. The major catalyst is its reported role in tokenized deposit settlement for 25 large U.S. banks.

The two projects show how wide the altcoin market has become:

  • NEAR represents Layer-1 expansion and on-chain activity.
  • QNT represents tokenized finance and bank settlement.
  • Both give buyers a way to follow infrastructure-led crypto growth.

For anyone watching altcoins under the radar, these are strong examples of how a clear real-world story can drive attention.

ZEC and XRP Are Gaining Attention Through Use Cases

Zcash trades near $1,530 after privacy assets moved into the institutional spotlight. Europe’s first physically backed Zcash ETP and increased interest in privacy technology have helped put ZEC on more crypto watchlists.

The privacy narrative is simple. Zcash uses shielded transaction technology that supports more private digital transfers. As the market pays more attention to financial privacy, ZEC is becoming a major name in that discussion.

XRP is also showing relative strength. It trades near $1.60 after back-to-back daily gains, even as the XRP Ledger’s Batch Upgrade was delayed to October 9. The asset’s use case remains tied to cross-border payment and remittance systems.

ZEC and XRP are different, but both have clear reasons for market attention:

  • ZEC is linked to privacy and institutional investment products.
  • XRP is linked to payment rails and the XRP Ledger ecosystem.
  • Each gives buyers a large-cap narrative beyond meme-driven price moves.

These use cases can keep both assets on the radar as altcoin markets look for projects with distinct product identities.

Should You Start Accumulating these Altcoins?

NEAR, QNT, ZEC, XRP, and MemeToro are gaining attention because each reflects a different crypto narrative. NEAR is tied to Layer-1 activity, QNT to tokenized settlement, ZEC to privacy, XRP to payment networks, and MemeToro to AI-powered memecoin creation.

For buyers who want to follow several emerging narratives, these five projects show how diverse the 2026 market has become. MemeToro stands out as the earlier entry because its launchpad, token utility, and trading roadmap are still expanding around the $MT ecosystem.

FAQs

Why is NEAR gaining attention?

NEAR is gaining attention after breaking a multi-month resistance channel and holding a key consolidation range near $4.79 to $5.00.

What is driving Quant’s move?

Quant is gaining attention after reports linked it to tokenized deposit settlement across 25 major U.S. banks.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Anthropic files for IPO: lost $4.2 billion last year, revenue grew 12x to $4.6 billion, risk section warns of "threats to human survival"

Anthropic's IPO prospectus reveals that its spending on computing power and infrastructure will reach $7.33 billion in 2025, a twofold increase from 2024, accounting for more than half of its total operating expenses of $12.65 billion. The company plans to continue investing over $500 billion in the future. The risk section of the prospectus extends to 80 pages, explicitly warning that its AI models could pose "catastrophic or even existential threats," and may even resist shutdowns or manipulate information.

华尔街见闻•2026/09/29 01:01
Meta shocks Wall Street by hiring MongoDB CEO and makes a high-profile entry into enterprise AI business

Meta has established an enterprise AI division called "Meta Enterprise Platform," which Mark Zuckerberg described as "the next important pillar." MongoDB CEO CJ Desai has been recruited to lead it. Analysts noted that Zuckerberg specifically poached a CEO from a publicly listed company to demonstrate the importance of this move. Desai's departure was announced just one day before Investor Day, with the timing surprising the public.

华尔街见闻•2026/09/29 00:51
AstraZeneca invests $2 billion in Summit, optimistic about Akeso's Ivose

This 18.6% premium subscription is not only a substantial endorsement, but both parties will also deeply collaborate on the joint development of combination therapies such as ADCs. The core of this deal is Akeso's Ivonescimab—the world’s first PD-1/VEGF bispecific antibody, and so far the only drug to have surpassed "K-drug" in head-to-head trials on both PFS and OS endpoints. The median OS reached 30.8 months, compared to 22.6 months for "K-drug", representing a 27% reduction in risk of death.

华尔街见闻•2026/09/29 00:26

Trending news

More
1
Anthropic files for IPO: lost $4.2 billion last year, revenue grew 12x to $4.6 billion, risk section warns of "threats to human survival"
2
Meta shocks Wall Street by hiring MongoDB CEO and makes a high-profile entry into enterprise AI business

Crypto prices

More
Bitcoin
Bitcoin
BTC
$83,132.75
-1.04%
Ethereum
Ethereum
ETH
$2,673.77
+0.07%
Tether USDt
Tether USDt
USDT
$0.9995
-0.04%
BNB
BNB
BNB
$761.35
-2.35%
XRP
XRP
XRP
$1.49
-1.44%
USDC
USDC
USDC
$0.9999
-0.00%
Solana
Solana
SOL
$118.1
-2.88%
TRON
TRON
TRX
$0.3352
+0.36%
Zcash
Zcash
ZEC
$1,453.05
-7.78%
Hyperliquid
Hyperliquid
HYPE
$86.68
-4.07%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now
Trade smarter